Proliferative Diabetic Retinopathy (PDR) Active Not Recruiting Phase 3 Trials for Brolucizumab (DB14864)
Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic
| Indication | Status | Phase |
|---|---|---|
| DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR)) | Active Not Recruiting | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04278417 | Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy | Treatment |